Patent · US Expired

Combined physical and immunotherapy for cancer

US6316007A · kind A · utility

12Cited by
25References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 19, 1998
Grant dateNov 13, 2001
Priority date
Expiry dateMar 19, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08B37/003
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention combines physical and immunologic therapies for the treatment of neoplasms by conditioning a targeted neoplasm with an immunoadjuvant (also called immuno-modulator or immunopotentiator) and then physically destroying the conditioned neoplasm. A number of physical therapies can be used to achieve the physical destruction of the conditioned tumor mass.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.